chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Magnetic resonance imaging
Clinical narrative: I was standing in bathroom, got super-hot flush from head to toe within 5 minutes gone and no; This spontaneous case was reported by a nurse and describes the occurrence of HOT FLUSH (I was standing in bathroom, got super-hot flush from head to toe within 5 minutes gone and no) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 041L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SPIRONOLACTONE and MINOCYCLINE for Acne, BIMATOPROST (LUMIGAN) for Dry eyes, CICLOSPORIN (RESTASIS) for Preglaucoma, unspecified, THYROID (ARMOUR THYROID) for Thyroid disorder, BUPROPION HYDROCHLORIDE (WELLBUTRIN) for Weight loss, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), FISH OIL, CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Dec-2020, the patient experienced HOT FLUSH (I was standing in bathroom, got super-hot flush from head to toe within 5 minutes gone and no). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form and CAFFEINE, PARACETAMOL (EXCEDRIN ASPIRIN FREE) ongoing since an unknown date at a dose of 1 dosage form. On 31-Dec-2020, HOT FLUSH (I was standing in bathroom, got super-hot flush from head to toe within 5 minutes gone and no) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: negative (Negative) negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Over the next several weeks, the patient had headaches that were all sharp and stabbing, but would migrate. Sometimes they were in the back of her head, sometimes behind one of her eyes, over her temporal lobe etc but they were all the exact same sharp, stabbing pains. All these weeks later, the patient still got the headaches, but they were less often and less intense.   This case was linked to MOD-2021-023660 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Patient information updated On 07-Jul-2021: Event verbatim was updated
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Rash
Clinical narrative: Big Rash; Very Tired; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Big Rash) and FATIGUE (Very Tired) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Big Rash) and FATIGUE (Very Tired). At the time of the report, RASH (Big Rash) was resolving and FATIGUE (Very Tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Concomitant medication was not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Vaccination site discolouration, Vaccination site reaction
Clinical narrative: Covid Arm; Coloration of a couple of inches on the injection site; Irritation on the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid Arm), VACCINATION SITE DISCOLOURATION (Coloration of a couple of inches on the injection site) and LIMB DISCOMFORT (Irritation on the arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE REACTION (Covid Arm), VACCINATION SITE DISCOLOURATION (Coloration of a couple of inches on the injection site) and LIMB DISCOMFORT (Irritation on the arm). At the time of the report, VACCINATION SITE REACTION (Covid Arm) and LIMB DISCOMFORT (Irritation on the arm) outcome was unknown and VACCINATION SITE DISCOLOURATION (Coloration of a couple of inches on the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No medical history information was reported. No concomitant medication was reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: NNI
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Raised red rash all the way down to her elbow on same arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Raised red rash all the way down to her elbow on same arm of injection) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Raised red rash all the way down to her elbow on same arm of injection). At the time of the report, RASH ERYTHEMATOUS (Raised red rash all the way down to her elbow on same arm of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Confusional state, Fatigue
Clinical narrative: mental clarity declined moderately/ Brain fog; Extremely weak with no residual energy; Fatigue, Still has extreme fatigue; Still suffering from brain fog; Rash that looked like Roseolovirus or Erythematous; Rash on abdominal area; Fever; Body felt hot; Sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Body felt hot), RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous), CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog), ASTHENIA (Extremely weak with no residual energy) and RASH (Rash on abdominal area) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced FEELING HOT (Body felt hot), VACCINATION SITE PAIN (Sore arm) and CHILLS (Chills). On 20-Feb-2021, the patient experienced PYREXIA (Fever). On 22-Feb-2021, the patient experienced RASH (Rash on abdominal area). On 23-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous). On 20-Jul-2021, the patient experienced FATIGUE (Fatigue, Still has extreme fatigue) and FEELING ABNORMAL (Still suffering from brain fog). On an unknown date, the patient experienced CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog) and ASTHENIA (Extremely weak with no residual energy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, FEELING HOT (Body felt hot), CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog), ASTHENIA (Extremely weak with no residual energy), RASH (Rash on abdominal area), VACCINATION SITE PAIN (Sore arm), CHILLS (Chills) and PYREXIA (Fever) had resolved with sequelae, RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous) had not resolved and FATIGUE (Fatigue, Still has extreme fatigue) and FEELING ABNORMAL (Still suffering from brain fog) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature: 100.5 f (High) 100.5 F.         No concomitant medications were provided by the reporter.   Treatment information was not provided.   This case was linked to MOD-2021-023499 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Significant Follow up
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Feeling hot, Pyrexia, Rash, Rash erythematous
Clinical narrative: mental clarity declined moderately/ Brain fog; Extremely weak with no residual energy; Fatigue, Still has extreme fatigue; Still suffering from brain fog; Rash that looked like Roseolovirus or Erythematous; Rash on abdominal area; Fever; Body felt hot; Sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Body felt hot), RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous), CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog), ASTHENIA (Extremely weak with no residual energy) and RASH (Rash on abdominal area) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced FEELING HOT (Body felt hot), VACCINATION SITE PAIN (Sore arm) and CHILLS (Chills). On 20-Feb-2021, the patient experienced PYREXIA (Fever). On 22-Feb-2021, the patient experienced RASH (Rash on abdominal area). On 23-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous). On 20-Jul-2021, the patient experienced FATIGUE (Fatigue, Still has extreme fatigue) and FEELING ABNORMAL (Still suffering from brain fog). On an unknown date, the patient experienced CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog) and ASTHENIA (Extremely weak with no residual energy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, FEELING HOT (Body felt hot), CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog), ASTHENIA (Extremely weak with no residual energy), RASH (Rash on abdominal area), VACCINATION SITE PAIN (Sore arm), CHILLS (Chills) and PYREXIA (Fever) had resolved with sequelae, RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous) had not resolved and FATIGUE (Fatigue, Still has extreme fatigue) and FEELING ABNORMAL (Still suffering from brain fog) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature: 100.5 f (High) 100.5 F.         No concomitant medications were provided by the reporter.   Treatment information was not provided.   This case was linked to MOD-2021-023499 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Significant Follow up
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: mental clarity declined moderately/ Brain fog; Extremely weak with no residual energy; Fatigue, Still has extreme fatigue; Still suffering from brain fog; Rash that looked like Roseolovirus or Erythematous; Rash on abdominal area; Fever; Body felt hot; Sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Body felt hot), RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous), CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog), ASTHENIA (Extremely weak with no residual energy) and RASH (Rash on abdominal area) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced FEELING HOT (Body felt hot), VACCINATION SITE PAIN (Sore arm) and CHILLS (Chills). On 20-Feb-2021, the patient experienced PYREXIA (Fever). On 22-Feb-2021, the patient experienced RASH (Rash on abdominal area). On 23-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous). On 20-Jul-2021, the patient experienced FATIGUE (Fatigue, Still has extreme fatigue) and FEELING ABNORMAL (Still suffering from brain fog). On an unknown date, the patient experienced CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog) and ASTHENIA (Extremely weak with no residual energy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, FEELING HOT (Body felt hot), CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog), ASTHENIA (Extremely weak with no residual energy), RASH (Rash on abdominal area), VACCINATION SITE PAIN (Sore arm), CHILLS (Chills) and PYREXIA (Fever) had resolved with sequelae, RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous) had not resolved and FATIGUE (Fatigue, Still has extreme fatigue) and FEELING ABNORMAL (Still suffering from brain fog) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature: 100.5 f (High) 100.5 F.         No concomitant medications were provided by the reporter.   Treatment information was not provided.   This case was linked to MOD-2021-023499 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Significant Follow up
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Pruritus
Clinical narrative: felt vaguely itchy; mildly short of breath; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (felt vaguely itchy) and DYSPNOEA (mildly short of breath) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN and TRIAMCINOLONE for an unknown indication.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (felt vaguely itchy) and DYSPNOEA (mildly short of breath). At the time of the report, PRURITUS (felt vaguely itchy) and DYSPNOEA (mildly short of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash erythematous, Vaccination site warmth
Clinical narrative: Rash is warm to touch; Raised red rash around injection site; Swollen armpit; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen armpit), VACCINATION SITE WARMTH (Rash is warm to touch) and RASH ERYTHEMATOUS (Raised red rash around injection site) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen armpit). On 24-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Rash is warm to touch) and RASH ERYTHEMATOUS (Raised red rash around injection site). At the time of the report, PERIPHERAL SWELLING (Swollen armpit), VACCINATION SITE WARMTH (Rash is warm to touch) and RASH ERYTHEMATOUS (Raised red rash around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Rash erythematous, Rash pruritic, Swelling
Clinical narrative: Itching at injection site; Red at injection site; Rash at the injection site; Red rash on jaw; Itching on jaw; Red rash on neck; Itching on neck; Lump on her jaw; Felt a little tired; Felt a change in her lungs when she breathed; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Felt a change in her lungs when she breathed), RASH ERYTHEMATOUS (Red rash on jaw), RASH PRURITIC (Itching on jaw), RASH ERYTHEMATOUS (Red rash on neck) and RASH PRURITIC (Itching on neck) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included THYROID and SIMVASTATIN for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced DYSPNOEA (Felt a change in her lungs when she breathed) and FATIGUE (Felt a little tired). On 12-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash on jaw), RASH PRURITIC (Itching on jaw), RASH ERYTHEMATOUS (Red rash on neck), RASH PRURITIC (Itching on neck) and SWELLING (Lump on her jaw). On 18-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE RASH (Rash at the injection site). At the time of the report, DYSPNOEA (Felt a change in her lungs when she breathed), RASH ERYTHEMATOUS (Red rash on jaw), RASH PRURITIC (Itching on jaw), RASH ERYTHEMATOUS (Red rash on neck), RASH PRURITIC (Itching on neck), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE RASH (Rash at the injection site) and FATIGUE (Felt a little tired) outcome was unknown and SWELLING (Lump on her jaw) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itching at injection site; Red at injection site; Rash at the injection site; Red rash on jaw; Itching on jaw; Red rash on neck; Itching on neck; Lump on her jaw; Felt a little tired; Felt a change in her lungs when she breathed; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Felt a change in her lungs when she breathed), RASH ERYTHEMATOUS (Red rash on jaw), RASH PRURITIC (Itching on jaw), RASH ERYTHEMATOUS (Red rash on neck) and RASH PRURITIC (Itching on neck) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included THYROID and SIMVASTATIN for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced DYSPNOEA (Felt a change in her lungs when she breathed) and FATIGUE (Felt a little tired). On 12-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash on jaw), RASH PRURITIC (Itching on jaw), RASH ERYTHEMATOUS (Red rash on neck), RASH PRURITIC (Itching on neck) and SWELLING (Lump on her jaw). On 18-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE ERYTHEMA (Red at injection site) and VACCINATION SITE RASH (Rash at the injection site). At the time of the report, DYSPNOEA (Felt a change in her lungs when she breathed), RASH ERYTHEMATOUS (Red rash on jaw), RASH PRURITIC (Itching on jaw), RASH ERYTHEMATOUS (Red rash on neck), RASH PRURITIC (Itching on neck), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE RASH (Rash at the injection site) and FATIGUE (Felt a little tired) outcome was unknown and SWELLING (Lump on her jaw) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Cough, Fatigue, Headache
Clinical narrative: Headache; chills; fever; Rash at injection site; swollen face; Fatigue; chest Congestion; Cough; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (chills), PYREXIA (fever), INJECTION SITE RASH (Rash at injection site) and SWELLING FACE (swollen face) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced HEADACHE (Headache), CHILLS (chills), PYREXIA (fever), INJECTION SITE RASH (Rash at injection site), SWELLING FACE (swollen face), FATIGUE (Fatigue), CHEST DISCOMFORT (chest Congestion) and COUGH (Cough). At the time of the report, HEADACHE (Headache), CHILLS (chills), PYREXIA (fever), INJECTION SITE RASH (Rash at injection site), SWELLING FACE (swollen face), FATIGUE (Fatigue), CHEST DISCOMFORT (chest Congestion) and COUGH (Cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Pyrexia, Swelling face
Clinical narrative: Headache; chills; fever; Rash at injection site; swollen face; Fatigue; chest Congestion; Cough; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (chills), PYREXIA (fever), INJECTION SITE RASH (Rash at injection site) and SWELLING FACE (swollen face) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced HEADACHE (Headache), CHILLS (chills), PYREXIA (fever), INJECTION SITE RASH (Rash at injection site), SWELLING FACE (swollen face), FATIGUE (Fatigue), CHEST DISCOMFORT (chest Congestion) and COUGH (Cough). At the time of the report, HEADACHE (Headache), CHILLS (chills), PYREXIA (fever), INJECTION SITE RASH (Rash at injection site), SWELLING FACE (swollen face), FATIGUE (Fatigue), CHEST DISCOMFORT (chest Congestion) and COUGH (Cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) had resolved.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site pain
Clinical narrative: pain at the injection site; shaking chills; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (pain at the injection site) and CHILLS (shaking chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder and Cholesterol. Concomitant products included Cholesterol medication and thyroid medication for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced INJECTION SITE PAIN (pain at the injection site) and CHILLS (shaking chills). On 04-Feb-2021, INJECTION SITE PAIN (pain at the injection site) and CHILLS (shaking chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Chills, Diarrhoea, Dizziness
Clinical narrative: really bad diarrhea; stomachache; arm was a little swollen; arm was painful; very tired; very tired and weak; fatigue; headache was severe; Felt achy; Dizziness; had chills; Muscle ache; headache; fatigue; This spontaneous case was reported by a physician and describes the occurrence of MYALGIA (Muscle ache), HEADACHE, the first episode of FATIGUE (fatigue), DIZZINESS (Dizziness) and CHILLS (had chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced MYALGIA (Muscle ache), HEADACHE, the first episode of FATIGUE (fatigue) and the second episode of FATIGUE (fatigue). On 20-Feb-2021, the patient experienced DIZZINESS (Dizziness), CHILLS (had chills) and HEADACHE (headache was severe). On 21-Feb-2021, the patient experienced VACCINATION SITE SWELLING (arm was a little swollen), PAIN IN EXTREMITY (arm was painful), FATIGUE (very tired) and ASTHENIA (very tired and weak). On 22-Feb-2021, the patient experienced DIARRHOEA (really bad diarrhea) and ABDOMINAL PAIN UPPER (stomachache). On an unknown date, the patient experienced PAIN (elt achy). The patient was treated with TRAMADOL for Back ache, at an unspecified dose and frequency; IBUPROFEN (ADVIL 12 HOUR) for Headache, at an unspecified dose and frequency and ONDANSETRON (ZOFRAN MELT) for Upset stomach, at an unspecified dose and frequency. At the time of the report, MYALGIA (Muscle ache), HEADACHE, DIZZINESS (Dizziness), CHILLS (had chills), VACCINATION SITE SWELLING (arm was a little swollen), PAIN IN EXTREMITY (arm was painful), DIARRHOEA (really bad diarrhea), ABDOMINAL PAIN UPPER (stomachache), the last episode of FATIGUE (fatigue), HEADACHE (headache was severe), FATIGUE (very tired) and ASTHENIA (very tired and weak) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were blood pressure medication, anti depressant medications. Medical history information was not provided. No concomitant medication was reported.  Reporter did not provide any causality assessments.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pain, Pain in extremity
Clinical narrative: really bad diarrhea; stomachache; arm was a little swollen; arm was painful; very tired; very tired and weak; fatigue; headache was severe; Felt achy; Dizziness; had chills; Muscle ache; headache; fatigue; This spontaneous case was reported by a physician and describes the occurrence of MYALGIA (Muscle ache), HEADACHE, the first episode of FATIGUE (fatigue), DIZZINESS (Dizziness) and CHILLS (had chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced MYALGIA (Muscle ache), HEADACHE, the first episode of FATIGUE (fatigue) and the second episode of FATIGUE (fatigue). On 20-Feb-2021, the patient experienced DIZZINESS (Dizziness), CHILLS (had chills) and HEADACHE (headache was severe). On 21-Feb-2021, the patient experienced VACCINATION SITE SWELLING (arm was a little swollen), PAIN IN EXTREMITY (arm was painful), FATIGUE (very tired) and ASTHENIA (very tired and weak). On 22-Feb-2021, the patient experienced DIARRHOEA (really bad diarrhea) and ABDOMINAL PAIN UPPER (stomachache). On an unknown date, the patient experienced PAIN (elt achy). The patient was treated with TRAMADOL for Back ache, at an unspecified dose and frequency; IBUPROFEN (ADVIL 12 HOUR) for Headache, at an unspecified dose and frequency and ONDANSETRON (ZOFRAN MELT) for Upset stomach, at an unspecified dose and frequency. At the time of the report, MYALGIA (Muscle ache), HEADACHE, DIZZINESS (Dizziness), CHILLS (had chills), VACCINATION SITE SWELLING (arm was a little swollen), PAIN IN EXTREMITY (arm was painful), DIARRHOEA (really bad diarrhea), ABDOMINAL PAIN UPPER (stomachache), the last episode of FATIGUE (fatigue), HEADACHE (headache was severe), FATIGUE (very tired) and ASTHENIA (very tired and weak) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were blood pressure medication, anti depressant medications. Medical history information was not provided. No concomitant medication was reported.  Reporter did not provide any causality assessments.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: really bad diarrhea; stomachache; arm was a little swollen; arm was painful; very tired; very tired and weak; fatigue; headache was severe; Felt achy; Dizziness; had chills; Muscle ache; headache; fatigue; This spontaneous case was reported by a physician and describes the occurrence of MYALGIA (Muscle ache), HEADACHE, the first episode of FATIGUE (fatigue), DIZZINESS (Dizziness) and CHILLS (had chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced MYALGIA (Muscle ache), HEADACHE, the first episode of FATIGUE (fatigue) and the second episode of FATIGUE (fatigue). On 20-Feb-2021, the patient experienced DIZZINESS (Dizziness), CHILLS (had chills) and HEADACHE (headache was severe). On 21-Feb-2021, the patient experienced VACCINATION SITE SWELLING (arm was a little swollen), PAIN IN EXTREMITY (arm was painful), FATIGUE (very tired) and ASTHENIA (very tired and weak). On 22-Feb-2021, the patient experienced DIARRHOEA (really bad diarrhea) and ABDOMINAL PAIN UPPER (stomachache). On an unknown date, the patient experienced PAIN (elt achy). The patient was treated with TRAMADOL for Back ache, at an unspecified dose and frequency; IBUPROFEN (ADVIL 12 HOUR) for Headache, at an unspecified dose and frequency and ONDANSETRON (ZOFRAN MELT) for Upset stomach, at an unspecified dose and frequency. At the time of the report, MYALGIA (Muscle ache), HEADACHE, DIZZINESS (Dizziness), CHILLS (had chills), VACCINATION SITE SWELLING (arm was a little swollen), PAIN IN EXTREMITY (arm was painful), DIARRHOEA (really bad diarrhea), ABDOMINAL PAIN UPPER (stomachache), the last episode of FATIGUE (fatigue), HEADACHE (headache was severe), FATIGUE (very tired) and ASTHENIA (very tired and weak) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were blood pressure medication, anti depressant medications. Medical history information was not provided. No concomitant medication was reported.  Reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pharyngeal swelling
Clinical narrative: Throat swelling; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Throat swelling) and HEADACHE (Headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On Apr-1942, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PHARYNGEAL SWELLING (Throat swelling) and HEADACHE (Headache). At the time of the report, PHARYNGEAL SWELLING (Throat swelling) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dry mouth, Gait inability, Headache, Nausea
Clinical narrative: inability to get off couch; very thirsty and cotton-mouth; unreal headache; a fever of 102; nausea; lack of appetite; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of GAIT INABILITY (inability to get off couch), DRY MOUTH (very thirsty and cotton-mouth), DECREASED APPETITE (lack of appetite), HEADACHE (unreal headache) and PYREXIA (a fever of 102) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced DECREASED APPETITE (lack of appetite). On 05-Feb-2021, the patient experienced GAIT INABILITY (inability to get off couch), DRY MOUTH (very thirsty and cotton-mouth), HEADACHE (unreal headache), PYREXIA (a fever of 102) and NAUSEA (nausea). At the time of the report, GAIT INABILITY (inability to get off couch), DRY MOUTH (very thirsty and cotton-mouth), DECREASED APPETITE (lack of appetite), HEADACHE (unreal headache), PYREXIA (a fever of 102) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: inability to get off couch; very thirsty and cotton-mouth; unreal headache; a fever of 102; nausea; lack of appetite; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of GAIT INABILITY (inability to get off couch), DRY MOUTH (very thirsty and cotton-mouth), DECREASED APPETITE (lack of appetite), HEADACHE (unreal headache) and PYREXIA (a fever of 102) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced DECREASED APPETITE (lack of appetite). On 05-Feb-2021, the patient experienced GAIT INABILITY (inability to get off couch), DRY MOUTH (very thirsty and cotton-mouth), HEADACHE (unreal headache), PYREXIA (a fever of 102) and NAUSEA (nausea). At the time of the report, GAIT INABILITY (inability to get off couch), DRY MOUTH (very thirsty and cotton-mouth), DECREASED APPETITE (lack of appetite), HEADACHE (unreal headache), PYREXIA (a fever of 102) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Taste disorder
Clinical narrative: arm was hurting; experienced a strong taste and smell of disinfect; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was hurting) and TASTE DISORDER (experienced a strong taste and smell of disinfect) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concomitant products included CARVEDILOL, DONEPEZIL, CLONAZEPAM, GABAPENTIN, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and MULTIVITAMIN & MINERAL for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was hurting) and TASTE DISORDER (experienced a strong taste and smell of disinfect). At the time of the report, PAIN IN EXTREMITY (arm was hurting) and TASTE DISORDER (experienced a strong taste and smell of disinfect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal pain, Pain in extremity
Clinical narrative: left butt cheeks; Left legs hurts; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL PAIN (left butt cheeks) and PAIN IN EXTREMITY (Left legs hurts) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced MUSCULOSKELETAL PAIN (left butt cheeks) and PAIN IN EXTREMITY (Left legs hurts). At the time of the report, MUSCULOSKELETAL PAIN (left butt cheeks) and PAIN IN EXTREMITY (Left legs hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Underdose, Vaccination site discharge
Clinical narrative: when the needle was pulled out, blood and serum leaked out; thinks did not get the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCHARGE (when the needle was pulled out, blood and serum leaked out) and UNDERDOSE (thinks did not get the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE DISCHARGE (when the needle was pulled out, blood and serum leaked out) and UNDERDOSE (thinks did not get the vaccine). On 25-Feb-2021, VACCINATION SITE DISCHARGE (when the needle was pulled out, blood and serum leaked out) and UNDERDOSE (thinks did not get the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Left side of face felt numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Left side of face felt numb) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced HYPOAESTHESIA (Left side of face felt numb). At the time of the report, HYPOAESTHESIA (Left side of face felt numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm is a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is a little sore) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm is a little sore). At the time of the report, PAIN IN EXTREMITY (arm is a little sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Updated event outcome from unknown to recovered/resolved.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Tenderness, Vaccination site induration, Vaccination site warmth
Clinical narrative: "still a red hole in my arm in that area; arm turned red; arm was also hot and warm; sore arm which went away eventually; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (sore arm which went away eventually), ERYTHEMA (arm turned red), VACCINATION SITE WARMTH (arm was also hot and warm) and VACCINATION SITE INDURATION ("still a red hole in my arm in that area) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced TENDERNESS (sore arm which went away eventually). On 13-Feb-2021, the patient experienced ERYTHEMA (arm turned red) and VACCINATION SITE WARMTH (arm was also hot and warm). On 23-Feb-2021, the patient experienced VACCINATION SITE INDURATION ("still a red hole in my arm in that area). At the time of the report, TENDERNESS (sore arm which went away eventually) had resolved and ERYTHEMA (arm turned red), VACCINATION SITE WARMTH (arm was also hot and warm) and VACCINATION SITE INDURATION ("still a red hole in my arm in that area) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache
Clinical narrative: headache; weakness; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and ASTHENIA (weakness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0412L20A and 0412L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced HEADACHE (headache) and ASTHENIA (weakness). At the time of the report, HEADACHE (headache) and ASTHENIA (weakness) outcome was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Cough, Fatigue, Influenza like illness, Pain in extremity
Clinical narrative: Itching Injection Site; Hurting Injection Site; Tender to the touch Injection Site; Sneezing; sore left arm; Flu like Symptoms; coughing; High Blood Sugar (>200 mg/dL); Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), INFLUENZA LIKE ILLNESS (Flu like Symptoms), COUGH (coughing), BLOOD GLUCOSE INCREASED (High Blood Sugar (>200 mg/dL)) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypertension.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore left arm), INFLUENZA LIKE ILLNESS (Flu like Symptoms), COUGH (coughing), BLOOD GLUCOSE INCREASED (High Blood Sugar (>200 mg/dL)), FATIGUE (Fatigue) and SNEEZING (Sneezing). On 20-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE PAIN (Hurting Injection Site) and VACCINATION SITE WARMTH (Tender to the touch Injection Site). On 12-Feb-2021, PAIN IN EXTREMITY (sore left arm), INFLUENZA LIKE ILLNESS (Flu like Symptoms), COUGH (coughing), BLOOD GLUCOSE INCREASED (High Blood Sugar (>200 mg/dL)) and SNEEZING (Sneezing) had resolved. At the time of the report, FATIGUE (Fatigue), VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE PAIN (Hurting Injection Site) and VACCINATION SITE WARMTH (Tender to the touch Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Itching Injection Site; Hurting Injection Site; Tender to the touch Injection Site; Sneezing; sore left arm; Flu like Symptoms; coughing; High Blood Sugar (>200 mg/dL); Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), INFLUENZA LIKE ILLNESS (Flu like Symptoms), COUGH (coughing), BLOOD GLUCOSE INCREASED (High Blood Sugar (>200 mg/dL)) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypertension.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore left arm), INFLUENZA LIKE ILLNESS (Flu like Symptoms), COUGH (coughing), BLOOD GLUCOSE INCREASED (High Blood Sugar (>200 mg/dL)), FATIGUE (Fatigue) and SNEEZING (Sneezing). On 20-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE PAIN (Hurting Injection Site) and VACCINATION SITE WARMTH (Tender to the touch Injection Site). On 12-Feb-2021, PAIN IN EXTREMITY (sore left arm), INFLUENZA LIKE ILLNESS (Flu like Symptoms), COUGH (coughing), BLOOD GLUCOSE INCREASED (High Blood Sugar (>200 mg/dL)) and SNEEZING (Sneezing) had resolved. At the time of the report, FATIGUE (Fatigue), VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE PAIN (Hurting Injection Site) and VACCINATION SITE WARMTH (Tender to the touch Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.